Rational Use of Drugs in Patients with Schizophrenia at Inpatient Installation of Dr. Soeharto Heerdjan Hospital Jakarta, Indonesia
DOI:
https://doi.org/10.18196/jmmr.v13i1.84Keywords:
Rational drug use, Schizophrenia, Antipsychotic drugs, Mental HealthAbstract
Schizophrenia is one of the mental health diseases in the inpatient department of Dr. Soeharto Heerdjan Hospital. Prescribing for Schizophrenia patients must be the right drug, the right patient, the right diagnosis, the right dose, and the right frequency of drug administration. This study aims to describe the use of drugs in patients with Schizophrenia in the inpatient installation at Dr. Soeharto Heerdjan Mental Hospital. The method used was a descriptive study of schizophrenia patients. The study population was patients of Dr. Soeharto Heerdjan Mental Hospital in the period October-December 2021. Total sampling with inclusion criteria was used from medical record data. The authors obtained 692 samples. The data is displayed in the form of a frequency distribution table. The results obtained were 69.83% male and 30.17% female; the youngest patient was 17 years old, and the oldest patient was 79 years old. The authors obtained 1765 prescriptions from single prescriptions to 54 drug combination prescriptions. Drug administration for Schizophrenia is the right patient, diagnosis, and frequency of drug administration, but still found 5.22% inappropriate drug administration and 5.22% inappropriate process. Overall, the rational use of drugs at Dr. Soeharto Heerdjan Mental Hospital is still within the limits of the rational drug use module issued by the Ministry of Health in 2011. However, there needs to be improvement (quality control) at the institution for drug therapy and dosage in schizophrenia patients because there are still cases of drug dose combinations that exceed the maximum dose when compared to drug rationality guidelines based on the Pharmacotherapy Handbook Ninth Edition Algorithms.
References
Badan Penelitian dan Pengembangan Kesehatan, K. K. R. (2019). Hasil Utama Riskesda 2018. https://kesmas.kemkes.go.id/assets/upload/dir_519d41d8cd98f00/files/Hasil-riskesdas-2018_1274.pdf
Bertram G. Katzung, Susan B. Masters, & Anthony J. Trevor. (2010). Antihypertensive Agents. In Annual Reports in Medicinal Chemistry (Vol. 12, Issue C). https://doi.org/10.1016/S0065-7743(08)61545-6
Civan Kahve, A., Kaya, H., Gül Çakıl, A., Ünverdi Bıçakçı, E., Göksel, P., Göka, E., & Böke, Ö. (2020). Multiple antipsychotics use in patients with Schizophrenia: Why do we use it, what are the results from patient follow-ups? Asian Journal of Psychiatry, 52(April). https://doi.org/10.1016/j.ajp.2020.102063
Dipiro, J. T., Wells, B. G., Schwinghammer, T. L., & DiPiro, C. V. (2015). Pharmacotherapy Handbook: Ninth Edition. In United States: McGraw-Hill Education.
Dixon, L. B., & Perkins, D. O. (1995). The drug treatment of patients with Schizophrenia. Drug and Therapeutics Bulletin, 33(11), 81–86. https://doi.org/10.1136/dtb.1995.331181
Elkis, H. (2007). Treatment-Resistant Schizophrenia. Psychiatric Clinics of North America, 30(3), 511–533. https://doi.org/https://doi.org/10.1016/j.psc.2007.04.001
Essock, S. M., Hargreaves, W. A., Covell, N. H., & Goethe, J. (1996). Clozapine’s effectiveness for patients in state hospitals: results from a randomized trial. Psychopharmacology Bulletin, 32(4), 683–697.
Fadilla, A. R., & Puspitasari, R. M. (2016). Evaluasi Ketepatan Penggunaan Antipsikotik Pada Pasien Skizofrenia Rawat Inap. Program Studi Farmasi. Fakultas Farmasi. Institut Sains dan Teknologi Nasional. Sainstech Farma, 9(1), 41–46.
Fahrul, Mukaddas, A., & Faustine, I. (2014). Rasionalitas Penggunaan Antipsikotik pada Pasien Skizofrenia di Instalasi Rawat Inap Jiwa RSD Madani Provinsi Sulawesi Tengah Periode Januari-April 2014. Online Journal of Natural Science, 3(1), 40–46.
Faqih, M., Hartanto, D., Farmasi, F., & Banjarmasin, U. M. (2021). Evaluation Of Antipsychotic Treatment In Skizofrenia Patients At Sambang Lihum Mental Hospital. Journal of Current Pharmaceutical Sciences, 5(1), 439–446. https://journal.umbjm.ac.id/index.php/jcps/article/view/764
Fond, G., Tinland, A., Boucekine, M., Girard, V., Loubière, S., Auquier, P., & Boyer, L. (2019). Prescription of potentially inappropriate psychotropic drugs in homeless people with Schizophrenia and bipolar disorders. Results from the French Housing First (FHF) program. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 89(June 2018), 84–89. https://doi.org/10.1016/j.pnpbp.2018.08.024
Gaebel, W., Zielasek, J., & Cleveland, H. R. (2012). Classifying psychosis - Challenges and opportunities. International Review of Psychiatry, 24(6), 538–548. https://doi.org/10.3109/09540261.2012.737313
Gaebel, W., Zielasek, J., & Cleveland, H. R. (2013). Psychotic disorders in ICD-11. Asian Journal of Psychiatry, 6(3), 263–265. https://doi.org/10.1016/j.ajp.2013.04.002
Girdler, S. J., Confino, J. E., & Woesner, M. E. (2019). Exercise as a Treatment for Schizophrenia: A Review. Psychopharmacology Bulletin, 49(1), 56–69.
Kesehatan Kemenkes RI. (2011). MODUL PENGGUNAAN OBAT RASIONAL.
Kuntarti, K. (2014). Tingkat Penerapan Prinsip ‘Enam Tepat’ Dalam Pemberian Obat Oleh Perawat Di Ruang Rawat Inap. Jurnal Keperawatan Indonesia, 9(1), 19–25. https://doi.org/10.7454/jki.v9i1.155
Labaka, A., Goñi-Balentziaga, O., Lebeña, A., & Pérez-Tejada, J. (2018). Biological Sex Differences in Depression: A Systematic Review. Biological Research for Nursing, 20(4), 383–392. https://doi.org/10.1177/1099800418776082
Lally, J., & MacCabe, J. H. (2015). Antipsychotic medication in Schizophrenia: A review. British Medical Bulletin, 114(1), 169–179. https://doi.org/10.1093/bmb/ldv017
Lieberman, J. A. (1999). Pathophysiologic mechanisms in the pathogenesis and clinical course of Schizophrenia. Journal of Clinical Psychiatry, 60(SUPPL. 12), 9–12.
Lindenmayer, J. P. (2000). Treatment refractory schizophrenia. The Psychiatric Quarterly, 71(4), 373–384. https://doi.org/10.1023/a:1004640408501
Maslim Rusdi. (2013). Buku Saku Diagnosis Gangguan Jiwa Rujukan Ringkas PPDGJ-III Dan DSM-5. Bagian Ilmu Kedokteran Jiwa FK-Unika Atmajaya.
National Institute of Mental Health. (2019). Mental Health Infomation Statistics : Schizophrenia. NIH. https://www.nimh.nih.gov/health/statistics/schizophrenia
Notoatmodjo, S. (2010). Metodologi Penelitian Kesehatan. Rineka Cipta.
Qiu, H., He, Y., Zhang, Y., He, M., Liu, J., Chi, R., Si, T., Wang, H., & Dong, W. (2018). Antipsychotic polypharmacy in the treatment of Schizophrenia in China and Japan. Australian and New Zealand Journal of Psychiatry, 52(12), 1202–1212. https://doi.org/10.1177/0004867418805559
Saha, S., Chant, D., Welham, J., & McGrath, J. (2005). A systematic review of the prevalence of Schizophrenia. PLoS Medicine, 2(5), 0413–0433. https://doi.org/10.1371/journal.pmed.0020141
Scott, G., Beauchamp-Lebrón, A. M., Rosa-Jiménez, A. A., Hernández-Justiniano, J. G., Ramos-Lucca, A., Asencio-Toro, G., & Jiménez-Chávez, J. (2021). Commonly diagnosed mental disorders in a general hospital system. International Journal of Mental Health Systems, 15(1), 1–13. https://doi.org/10.1186/s13033-021-00484-w
Tandon, R., Gaebel, W., Barch, D. M., Bustillo, J., Gur, R. E., Heckers, S., Malaspina, D., Owen, M. J., Schultz, S., Tsuang, M., Van Os, J., & Carpenter, W. (2013). Definition and description of Schizophrenia in the DSM-5. Schizophrenia Research, 150(1), 3–10. https://doi.org/10.1016/j.schres.2013.05.028
Wang, J., Jiang, F., Zhang, Y., Cotes, R. O., Yang, Y., Liu, Z., Ning, X., Liu, T., Liu, Y., Tang, Y. lang, & Liu, H. (2021). Patterns of antipsychotic prescriptions in patients with Schizophrenia in China: A national survey. Asian Journal of Psychiatry, 62(June), 102742. https://doi.org/10.1016/j.ajp.2021.102742
World Health Organization (WHO). (2022). Fact-Sheets Schizophrenia. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/schizophrenia
Downloads
Published
Issue
Section
License
Copyright (c) 2024 JMMR (Jurnal Medicoeticolegal dan Manajemen Rumah Sakit)
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
